Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Johnson and Johnson
Cipla
Boehringer Ingelheim
Argus Health
Accenture
Express Scripts
McKinsey

Generated: April 23, 2018

DrugPatentWatch Database Preview

DESFERAL Drug Profile

« Back to Dashboard

Which patents cover Desferal, and when can generic versions of Desferal launch?

Desferal is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in DESFERAL is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
Drug patent expirations by year for DESFERAL
Pharmacology for DESFERAL
Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity
Medical Subject Heading (MeSH) Categories for DESFERAL
Synonyms for DESFERAL
138-14-7
138D147
17688-38-9
35908-62-4
A807339
AB0035971
AC1L1XZ1
AC1Q5IOG
AKOS026750165
AN-43810
Ba 33122
BC667333
Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate
C25H48N6O8.CH4O3S
C26H52N6O11S
CAS-138-14-7
CCG-39770
CCRIS 8311
CHEBI:31460
CHEMBL1234
CS-4479
CTK8F9000
D01186
D0FJ8A
Deferoxamine (mesylate)
Deferoxamine B mesylate
Deferoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard
Deferoxamine mesilate
Deferoxamine mesilate (JP17)
Deferoxamine mesylate
Deferoxamine mesylate (USP)
Deferoxamine mesylate [USAN:USP]
Deferoxamine mesylate [USAN]
Deferoxamine mesylate salt
Deferoxamine mesylate salt, European Pharmacopoeia (EP) Reference Standard
Deferoxamine mesylate salt, powder, >=92.5% (TLC)
Deferoxamine mesylate, United States Pharmacopeia (USP) Reference Standard
Deferoxamine methanesulfonate
Deferoxamine methanesulfonate salt
Deferoxamine-D8 mesylate
DEFEROXAMINE; METHANESULFONIC ACID
Deferrioxamine B methanesulfonate
Deforoxamine B mesylate
Desferal (TN)
Desferal mesylate
Desferal methanesulfonate
Desferioxamine mesylate
Desferrioxamine B mesylate
Desferrioxamine B methanesulfonate
DESFERRIOXAMINE MESILATE
Desferrioxamine mesylate
Desferrioxamine mesylate salt
Desferrioxamine methanesulfonate
DFX mesylate
DSSTox_CID_17649
DSSTox_GSID_37649
DSSTox_RID_79351
DTXSID6037649
EINECS 205-314-3
FT-0603121
HMS1570A12
HMS1920C16
HMS2091K08
HMS2097A12
HMS2234H23
HMS500E04
HY-B0988
I14-98954
IDDIJAWJANBQLJ-UHFFFAOYSA-N
KSC959A0B
LP086427
LS-124966
MFCD00058605
MLS000028713
MolPort-003-666-154
N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid monomethanesulfonate (salt)
N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; methanesulfonic acid
N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; methanesulfonic acid
N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid
N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid Methanesulfonate
N'-(5-azanylpentyl)-N-[5-[[4-[5-[ethanoyl(oxidanyl)amino]pentylamino]-4-oxidanylidene-butanoyl]-oxidanyl-amino]pentyl]-N'-oxidanyl-butanediamide; methanesulfonic acid
N'-{5-[acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxysuccinamide methanesulfonate (salt)
n'-{5-[acetyl(hydroxy)amino]pentyl}-n-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-n-hydroxysuccinamide methanesulfonate(1:1)
N1-(5-aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide Methanesulfonate
N4-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxybutanediamide methanesulfonate
N4-[5-[[4-5-(Acetylhydroxyamino)pentyl]-1,4-dioxobutyl]hydroxyaminopentyl-N1-(5-aminopentyl)-N1-hydroxybutanediamide methanesulfonate
NCGC00017021-01
NCGC00017021-02
NCGC00017021-03
NCGC00094640-01
NCGC00094640-02
NCGC00178802-06
NSC 644468
NSC-644468
NSC-756718
NSC644468
NSC756718
Pharmakon1600-01500224
Prestwick_988
Propionohydroxamic acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)-, monomethanesulfonate (salt)
SCHEMBL119982
SMR000058548
SPECTRUM1500224
SR-01000695424
SR-01000695424-2
ST24046423
Tox21_110741
Tox21_110741_1
UNII-V9TKO7EO6K
V9TKO7EO6K
Y0490

US Patents and Regulatory Information for DESFERAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis DESFERAL deferoxamine mesylate INJECTABLE;INJECTION 016267-002 May 25, 2000 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis DESFERAL deferoxamine mesylate INJECTABLE;INJECTION 016267-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Medtronic
McKinsey
Deloitte
Harvard Business School
Cantor Fitzgerald
Colorcon
Dow
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.